AN2 Therapeutics Inc
Biotechnology
Healthcare
ANTX
29.84 M shares
NASDAQ US
traded
03 Apr 2025
listed
no
open
1.36
52 week high
3.76
high
1.41
52 week low
0.98
previous Close
1.40
P/E ratio
market cap
37.65 M
div yield
0
net incoming
-12.75 M
11.69 %
net profit margin
-1274700000.00 %
0.00 %
operating incoming
-14.01 M
11.75 %
net change in cash
6.74 M
224.42 %
cash on hand
33.50 M
25.16 %
top